Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 2
1999 1
2006 1
2008 1
2014 2
2015 4
2016 5
2017 5
2018 8
2019 3
2020 7
2021 11
2022 11
2023 9

Text availability

Article attribute

Article type

Publication date

Search Results

61 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
Gnant M, Dueck AC, Frantal S, Martin M, Burstein HJ, Greil R, Fox P, Wolff AC, Chan A, Winer EP, Pfeiler G, Miller KD, Colleoni M, Suga JM, Rubovsky G, Bliss JM, Mayer IA, Singer CF, Nowecki Z, Hahn O, Thomson J, Wolmark N, Amillano K, Rugo HS, Steger GG, Hernando Fernández de Aránguiz B, Haddad TC, Perelló A, Bellet M, Fohler H, Metzger Filho O, Jallitsch-Halper A, Solomon K, Schurmans C, Theall KP, Lu DR, Tenner K, Fesl C, DeMichele A, Mayer EL; PALLAS groups and investigators. Gnant M, et al. Among authors: haddad tc. J Clin Oncol. 2022 Jan 20;40(3):282-293. doi: 10.1200/JCO.21.02554. Epub 2021 Dec 7. J Clin Oncol. 2022. PMID: 34874182 Free PMC article. Clinical Trial.
Chemotherapy-induced thrombosis.
Haddad TC, Greeno EW. Haddad TC, et al. Thromb Res. 2006;118(5):555-68. doi: 10.1016/j.thromres.2005.10.015. Epub 2006 Jan 4. Thromb Res. 2006. PMID: 16388837 Review.
Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
Mayer EL, Fesl C, Hlauschek D, Garcia-Estevez L, Burstein HJ, Zdenkowski N, Wette V, Miller KD, Balic M, Mayer IA, Cameron D, Winer EP, Ponce Lorenzo JJ, Lake D, Pristauz-Telsnigg G, Haddad TC, Shepherd L, Iwata H, Goetz M, Cardoso F, Traina TA, Sabanathan D, Breitenstein U, Ackerl K, Metzger Filho O, Zehetner K, Solomon K, El-Abed S, Theall KP, Lu DR, Dueck A, Gnant M, DeMichele A. Mayer EL, et al. Among authors: haddad tc. J Clin Oncol. 2022 Feb 10;40(5):449-458. doi: 10.1200/JCO.21.01918. Epub 2022 Jan 7. J Clin Oncol. 2022. PMID: 34995105 Free PMC article. Clinical Trial.
Avoiding the "Faux Equalizer".
Pritchett JC, Haddad TC. Pritchett JC, et al. Among authors: haddad tc. Mayo Clin Proc. 2021 Dec;96(12):2963-2965. doi: 10.1016/j.mayocp.2021.08.010. Epub 2021 Oct 30. Mayo Clin Proc. 2021. PMID: 34728058 Free PMC article. No abstract available.
Updates in the Evaluation and Management of Breast Cancer.
O'Sullivan CC, Loprinzi CL, Haddad TC. O'Sullivan CC, et al. Among authors: haddad tc. Mayo Clin Proc. 2018 Jun;93(6):794-807. doi: 10.1016/j.mayocp.2018.03.025. Mayo Clin Proc. 2018. PMID: 29866283 Review.
Cardiovascular Concerns in BRCA1 and BRCA2 Mutation Carriers.
Gast KC, Viscuse PV, Nowsheen S, Haddad TC, Mutter RW, Wahner Hendrickson AE, Couch FJ, Ruddy KJ. Gast KC, et al. Among authors: haddad tc. Curr Treat Options Cardiovasc Med. 2018 Mar 1;20(2):18. doi: 10.1007/s11936-018-0609-z. Curr Treat Options Cardiovasc Med. 2018. PMID: 29497862 Review.
Landscape of neoadjuvant therapy for breast cancer.
Haddad TC, Goetz MP. Haddad TC, et al. Ann Surg Oncol. 2015 May;22(5):1408-15. doi: 10.1245/s10434-015-4405-7. Epub 2015 Mar 2. Ann Surg Oncol. 2015. PMID: 25727557 Free PMC article. Review.
61 results